|
Toward complement inhibition 2.0: Next generation anticomplement agents for paroxysmal nocturnal hemoglobinuria
|
Jan 2018
|
Am J Hematol
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
|
Hypomethylating agents in combination with immune checkpoint inhibitors in acute myeloid leukemia and myelodysplastic syndromes
|
Feb 2018
|
Leukemia
|
myelodysplastic syndromes (MDS)
|
|
Aplastic anemia during pregnancy: a review of obstetric and anesthetic considerations
|
Feb 2018
|
Int J Womens Health
|
aplastic anemia
|
|
Patient-Reported Distress in Myelodysplastic Syndromes and Its Association With Clinical Outcomes: A Retrospective Cohort Study
|
Mar 2018
|
J Natl Compr Canc Netw
|
myelodysplastic syndromes (MDS)
|
|
Concurrent treatment of aplastic anemia/Paroxysmal Nocturnal Hemoglobinuria syndrome with immunosuppressive therapy and eculizumab: a UK experience
|
Mar 2018
|
Haematologica
|
aplastic anemia, paroxysmal nocturnal hemoglobinuria (PNH)
|
|
Eltrombopag mobilizes iron in patients with aplastic anemia
|
Apr 2018
|
Blood
|
aplastic anemia
|
|
Iron Overload in Myelodysplastic Syndromes: Pathophysiology, Consequences, Diagnosis, and Treatment.
|
May 2018
|
J Adv Pract Oncol
|
myelodysplastic syndromes (MDS)
|
|
(Auto-)immune signature in aplastic anemia.
|
May 2018
|
Haematologica
|
acute myeloid leukemia (AML)
|
|
Unmanipulated Haploidentical Hematopoietic Stem Cell Transplantation Achieved Outcomes Comparable With Matched Unrelated Donor Transplantation in Young Acquired Severe Aplastic Anemia
|
May 2018
|
Biol Blood Marrow Transplant
|
acute myeloid leukemia (AML)
|
|
Society of Hematologic Oncology (SOHO) State of the Art Updates and Next Questions: Myelodysplastic Syndromes
|
May 2018
|
Clin Lymphoma Myeloma Leuk
|
myelodysplastic syndromes (MDS)
|
